This work expands our current knowledge regarding the function of UGT2B17 in CLL by placing this protein as a component of the BCR signalosome and at the crossroad of the BCR signalosome and the interleukin/JAK/STAT6 pro-survival pathways. Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.